BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 6437432)

  • 41. Lambda light chain predominance as a sign of emerging lymphoma.
    Bray M; Alper MG
    Am J Clin Pathol; 1983 Oct; 80(4):526-8. PubMed ID: 6414286
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis and detection of B cell neoplasms.
    Frenkel EP; Smith RG; Ligler FS; Hernandez J; Himes JB; Sheehan RG; Vitetta ES; Kettman JR; Uhr JW
    Blood Cells; 1980; 6(4):783-98. PubMed ID: 6781556
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunoglobulin isotypes on monoclonal blood lymphocytes in human plasma cell myeloma.
    Pettersson D; Mellstedt H; Holm G
    J Clin Lab Immunol; 1980 Mar; 3(2):93-8. PubMed ID: 6782249
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine.
    Campbell JP; Cobbold M; Wang Y; Goodall M; Bonney SL; Chamba A; Birtwistle J; Plant T; Afzal Z; Jefferis R; Drayson MT
    J Immunol Methods; 2013 May; 391(1-2):1-13. PubMed ID: 23388695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum-free light chain analysis: works in progress.
    Merlini G
    Clin Chem Lab Med; 2009; 47(9):1021-2. PubMed ID: 19728842
    [No Abstract]   [Full Text] [Related]  

  • 46. Light chain composition of IgA in IgA nephropathy.
    Lai KN; Lai FM; Lo ST; Lam CW
    Am J Kidney Dis; 1988 May; 11(5):425-9. PubMed ID: 3130751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Free light chains of immunoglobulins in serum from patients with leukaemias and multiple myeloma.
    Sølling K; Nielsen JL; Sølling J; Ellegaard J
    Scand J Haematol; 1982 Apr; 28(4):309-18. PubMed ID: 6810451
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel multiparametric approach for analysis of cytoplasmic immunoglobulin light chains by flow cytometry.
    Chang CC; Schur BC; Kampalath B; Lindholm P; Becker CG; Vesole DH
    Mod Pathol; 2001 Oct; 14(10):1015-21. PubMed ID: 11598172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple myeloma: light chain isotype suppression--a marker of stable disease at presentation.
    Wearne AJ; Joshua DE; Young GA; Kronenberg H
    Eur J Haematol; 1987 Jan; 38(1):43-9. PubMed ID: 3108026
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Contribution of new methods of quantitative cytology and immunology to the understanding of lymphoproliferative syndromes].
    Dighiero G; Binet JL
    C R Seances Soc Biol Fil; 1979; 173(2):213-20. PubMed ID: 92356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The export of immunoglobulin D by human neoplastic B lymphocytes.
    Stevenson FK; Stevenson GT; Tutt AL
    J Exp Med; 1983 Jan; 157(1):337-41. PubMed ID: 6401318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunoturbidimetric assay for estimating free light chains of immunoglobulins in urine and serum.
    Tillyer CR; Iqbal J; Raymond J; Gore M; McIlwain TJ
    J Clin Pathol; 1991 Jun; 44(6):466-71. PubMed ID: 1906071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phagocytic, lambda light chain, plasma cell myeloma.
    Wirt DP; Grogan TM; Payne CM; Kummet TD; Durie BG; Finley PR; Rollins D
    Am J Clin Pathol; 1983 Jul; 80(1):75-84. PubMed ID: 6190396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunopathology of follicular lymphomas. A model of B-lymphocyte homing.
    Warnke R; Levy R
    N Engl J Med; 1978 Mar; 298(9):481-6. PubMed ID: 414136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of immunoglobulin light chain analysis to detect bone marrow involvement in B-cell neoplasms.
    Sobol RE; Astarita RW; Chisari FV; Griffiths JC; Royston I
    Clin Immunol Immunopathol; 1982 Jul; 24(1):139-44. PubMed ID: 6809381
    [No Abstract]   [Full Text] [Related]  

  • 57. [Monoclonal plasmocytic myeloma with 2 paraproteins, IgG kappa and IgG lambdal].
    Villiamey J; Bouvet JP; Di Menza C; Boccara M
    Nouv Presse Med; 1974 Dec; 3(45):2707-11. PubMed ID: 4142506
    [No Abstract]   [Full Text] [Related]  

  • 58. Detection of monoclonal B lymphocytes in multiple myeloma by immunofluorescence tests of surface immunoglobulins.
    Sato I; Abo T; Onodera S; Kumagai K
    Scand J Haematol; 1978 Nov; 21(5):433-44. PubMed ID: 366730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic lambda light-chain deposition in a patient with myeloma.
    Ganeval D; Noël LH; Droz D; Leibowitch J
    Br Med J (Clin Res Ed); 1981 Feb; 282(6265):681-3. PubMed ID: 6781614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Abnormal kappa:lambda light chain ratio in circulating immune complexes as a marker for B cell activity in juvenile idiopathic arthritis.
    Low JM; Chauhan AK; Moore TL
    Scand J Immunol; 2007 Jan; 65(1):76-83. PubMed ID: 17212770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.